Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.43 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.43 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 5/20 | 0.43 |
| ▸ | GRM8 | O00222 | 1/20 | 0.41 |
| ▸ | GRM6 | O15303 | 1/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.41 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.41 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.41 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12266591 | 1.00 | CA2 (0.50) | CA2MEN1KMT2ADPP4DPP8 | |
| SCHEMBL12599304 | 0.92 | DPP7 (0.44) | CA2DPP4DPP8DPP9TLR2 | |
| SCHEMBL25698855 | 0.90 | CA2 (0.43) | CA2MEN1KMT2ADPP4DPP8 | |
| SCHEMBL25708285 | 0.88 | MEN1 (0.46) | CA2MEN1KMT2ATLR2DPP7 | |
| SCHEMBL13818496 | 0.85 | CA2 (0.42) | CA2MEN1KMT2ADPP4DPP8 | |
| SCHEMBL29430501 | 0.85 | MEN1 (0.49) | CA2MEN1KMT2ATLR2S1PR1 | |
| SCHEMBL15507860 | 0.83 | MEN1 (0.42) | CA2MEN1KMT2ATLR2DPP7 | |
| SCHEMBL29131983 | 0.82 | PLK1 (0.42) | CA2MEN1KMT2ATLR2DPP7 | |
| SCHEMBL26232048 | 0.82 | PLK1 (0.42) | CA2MEN1KMT2ATLR2DPP7 | |
| SCHEMBL31756841 | 0.82 | PLK1 (0.42) | CA2MEN1KMT2ATLR2DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12077606-B2 | Cyclic peptide analogs and conjugates thereof | SIRENAS LLC (US) | 2024-09-03 | — | — | US | disclosed |
| US-20220227808-A1 | CYCLIC PEPTIDE ANALOGS AND CONJUGATES THEREOF | SIRENAS LLC | 2022-07-21 | — | — | US | disclosed |
| US-11254705-B2 | Cyclic peptide analogs and conjugates thereof | SIRENAS LLC (US) | 2022-02-22 | — | — | US | disclosed |
| US-20190211060-A1 | CYCLIC PEPTIDE ANALOGS AND CONJUGATES THEREOF | SIRENAS LLC (US) | 2019-07-11 | — | — | US | disclosed |
| US-20180156810-A1 | FLUORESCENT COMPOUNDS | BIOTIUM, INC. | 2018-06-07 | — | — | US | disclosed |
| US-9791450-B2 | Fluorescent compounds | BIOTIUM, INC. (US) | 2017-10-17 | — | — | US | disclosed |
| US-20160033520-A1 | FLUORESCENT COMPOUNDS | BIOTIUM, INC. | 2016-02-04 | — | — | US | disclosed |
| US-9097667-B2 | Fluorescent compounds | BIOTIUM, INC. (US) | 2015-08-04 | — | — | US | disclosed |
| US-20090305410-A1 | FLUORESCENT COMPOUNDS | BIOTIUM, INC. (US) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190211060-A1 | CYCLIC PEPTIDE ANALOGS AND CONJUGATES THEREOF | VIP, NGLY1, GRPR | CA2 3904/4885MEN1 164/4885KMT2A 4259/4885 |
| US-11254705-B2 | Cyclic peptide analogs and conjugates thereof | VIP, NGLY1, GRPR | CA2 3904/4885MEN1 164/4885KMT2A 4259/4885 |
| US-20090305410-A1 | FLUORESCENT COMPOUNDS | MKI67, CD68, CA5B | CA2 784/4885MEN1 1677/4885KMT2A 3471/4885 |
| US-12077606-B2 | Cyclic peptide analogs and conjugates thereof | VIP, NGLY1, GRPR | CA2 3904/4885MEN1 164/4885KMT2A 4259/4885 |
| US-20220227808-A1 | CYCLIC PEPTIDE ANALOGS AND CONJUGATES THEREOF | VIP, NGLY1, GRPR | CA2 3904/4885MEN1 164/4885KMT2A 4259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.